Brief: Amphastar Pharmaceuticals Q4 EPS USD 0.51
26/02/2026 21:05
Feb 26 (Reuters) - Amphastar Pharmaceuticals Q4 adjusted EPS USD 0.73 vs. IBES estimate USD 0.92. Q4 net income USD 24.429 million Q4 adjusted net income USD 34.158 million vs. IBES estimate USD 43.6 million Q4 revenue USD 183.105 million vs. IBES estimate USD 190.5 million
Recent news on Amphastar Pharmaceuticals
See all newsAmphastar Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Amphastar Pharmaceuticals Q2 EPS USD 0.67
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending
U.S. STOCKS ON THE MOVE-Amkor Technology, Dynatrace, Corvex
Amphastar rises after FDA approves new over-the-counter overdose spray